Target intelligence / Profile preview

Hepatitis C Virus (HCV)

Target
HCV
Molecular classification
Virus, RNA virus, Flaviviridae, Hepacivirus
01

Overview

The hepatitis C virus (HCV) is a bloodborne, single-stranded RNA virus that causes hepatitis C, an infectious disease primarily affecting the liver. It is classified within the Flaviviridae family, genus Hepacivirus. The virus particle comprises an envelope with glycoproteins E1 and E2, mediating cell entry, and a core containing the RNA genome. The genome encodes a polyprotein that is cleaved into structural (Core, E1, E2) and nonstructural proteins (p7, NS2, NS3, NS4A, NS4B, NS5A, NS5B), which are key for replication. HCV is primarily transmitted through exposure to infected blood. Chronic infection can lead to cirrhosis, liver failure, and hepatocellular carcinoma. Direct acting antivirals (DAAs) target viral proteins and can achieve high cure rates.

02

Mechanism of action

DAAs inhibit specific viral proteins essential for HCV replication, such as NS3/4A protease, NS5A protein, and NS5B RNA polymerase.

03

Biological functions

Viral replicationInfection of hepatocytesEvading immune response
04

Disease associations

Hepatitis CCirrhosisLiver failureHepatocellular carcinoma
05

Safety considerations

Drug resistanceDrug-drug interactionsAdverse effects of DAAs (fatigue, headache, nausea)Lack of vaccine
06

Interacting drugs

Direct Acting Antivirals (DAAs)
07

Biomarkers

HCV RNA levelsHCV genotypeLiver enzyme levels (ALT, AST)Liver fibrosis stage

Beyond the preview

Go deeper on Hepatitis C Virus (HCV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis C Virus (HCV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call